Taken together, our findings suggest that the combination of TRAIL and LA synergistically induces apoptosis in non-small cell lung cancer cells via the inhibition of XIAP/NF-κB as a potent TRAIL sensitizer. Here, XIAP is linked to non-small cell lung carcinoma.